Research Article

Effect of Berberine on PPARα/NO Activation in High Glucose- and Insulin-Induced Cardiomyocyte Hypertrophy

Table 2

Effect of berberine on cardiomyocyte hypertrophy induced by high glucose and insulin (HGI).

Group (μmol/L)Cell surface areaProtein levelANF mRNA
(μm2/cell; n = 3)(μg/106 cell; n = 6)(n = 3)

Control459.7 ± 64.123.1 ± 5.330.6 ± 6.4
HGI1229.6 ± 99.5*47.3 ± 3.6*179.4 ± 25.5*
HGI + berberine (3)711.2 ± 43.0#37.4 ± 2.0#81.8 ± 7.5#
HGI + fenofibrate (0.3)678.9 ± 21.3#33.8 ± 6.0#37.9 ± 9.5#
HGI + MK886 (0.3)1208.8 ± 27.149.9 ± 5.9184.7 ± 22.3
HGI + fenofibrate (0.3) + MK886 (0.3)1212.4 ± 82.750.2 ± 5.1161.5 ± 36.5
HGI + berberine (3) + MK886 (0.3)1257.4 ± 29.647.2 ± 3.3154.0 ± 17.6
HGI + L-arginine (100)768.1 ± 49.0#38.6 ± 4.1#80.7 ± 8.7#
HGI + L-NAME (100)1213.1 ± 84.048.1 ± 3.5147.3 ± 20.4
HGI + L-arginine (100) + L-NAME (100)1199.9 ± 75.748.8 ± 4.9163.3 ± 20.8
HGI + berberine (3) + L-NAME (100)972.4 ± 41.143.9 ± 2.1110.0 ± 9.5

ANF: atrial natriuretic factor; L-NAME: -nitro-L-arginine-methyl ester. Results are mean ± SEM of n independent experiments. *P < 0.05 versus control; #P < 0.05 versus HGI; P < 0.05 versus HGI + fenofibrate (0.3 μmol/L); P < 0.05 versus HGI + berberine (3 μmol/L); P < 0.05 versus HGI + L-arginine (100 μmol/L).